Viscosity Drift after excipient change: process controls for moulding, filling, and storage


Published on 29/12/2025

Analyzing Viscosity Drift Following an Excipient Change in Pharmaceutical Manufacturing

Viscosity drift represents a common challenge following an excipient change in pharmaceutical formulations, particularly for rectal and vaginal dosage forms. This issue can disrupt the quality of the final product, leading to out-of-specification (OOS) results that complicate compliance with Good Manufacturing Practice (GMP) regulations. In this article, we will conduct a thorough investigation into viscosity drift issues, outlining practical steps for professionals in manufacturing, quality control (QC), and regulatory roles to identify and resolve the underlying causes effectively.

Reading through this article will equip you with actionable strategies for investigating viscosity drift due to excipient changes, detailing the essential steps for signal detection, root cause analysis, and the implementation of corrective and preventive actions (CAPA). You will gain insights to streamline your investigation process and maintain compliance with regulatory expectations, thus enhancing operational efficiencies.

Symptoms/Signals on the Floor or in the Lab

Recognizing the signs of viscosity drift is crucial for effective monitoring and response. Symptoms may present as quality control

deviations, customer complaints, process inefficiencies, or anomalies detected during routine testing. Typical indicators include:

  • Increased Viscosity Measurements: Laboratory results showing viscosity values that exceed predetermined specifications.
  • Homogeneity Issues: Observations of phase separation or non-uniform texture in formulations.
  • Production Delays: Increased time in processing due to viscosity-related challenges during mixing, moulding, or filling.
  • Equipment Performance: Abnormal wear patterns on pumps, valves, and other components due to unexpected changes in fluid dynamics.

Identifying these symptoms early allows for timely investigation and mitigation strategies to avoid potential regulatory consequences.

Explore the full topic: Dosage Forms & Drug Delivery Systems

Likely Causes

To effectively address viscosity drift, it is essential first to categorize the potential causes. Utilizing the “5Ms”—Materials, Method, Machine, Man, Measurement, and Environment—can help in systematically identifying possible issues:

Category Possible Causes
Materials Use of different excipients or properties due to batch changes, incorrect blending ratios.
Method Changes in processing parameters such as temperature, mixing speed, or stirring time.
Machine Equipment calibration issues, wear and tear affecting operational efficiency.
Man Operator error during formulation handling or processing steps.
Measurement Calibration failures in viscometers or other measurement devices leading to inaccurate data.
Environment Temperature and humidity fluctuations impacting excipient behavior.
Pharma Tip:  Odor Change during method transfer: mixing and sampling controls for QA review

Immediate Containment Actions (First 60 Minutes)

The first hour following the detection of viscosity drift is critical for containment. Immediate actions should include:

  • Stop Production: Halt the production line to prevent further processing of potentially non-compliant batches.
  • Quarantine Affected Materials: Isolate all batches containing the altered excipient to avoid contamination and ensure controlled sampling.
  • Notify Quality Control: Alert QC personnel to initiate an investigation and assess any impacted products.
  • Review Testing Protocols: Ensure that viscosity testing methods are correctly applied and recent calibration checks are verified.

These first-response actions will protect product integrity and ensure compliance with regulatory standards, allowing for a structured approach to further investigation.

Investigation Workflow

A systematic investigation is critical for identifying the root cause of viscosity drift. The workflow should consist of the following key steps:

  1. Data Collection: Gather samples from the affected batch alongside viscosity measurements, ingredient specifications, historical data on excipients, and processing parameters.
  2. Document Review: Examine production logs, batch records, and testing results to trace deviations or discrepancies during the manufacturing process.
  3. Interviews: Conduct discussions with operators, QC personnel, and other relevant staff to uncover contextual clues surrounding the incident.
  4. Data Analysis: Analyze patterns and correlations across collected data to identify potential sources of variability.

Interpreting this data effectively is fundamental to uncovering root causes and forming hypotheses on what may have contributed to the viscosity drift.

Root Cause Tools

Employing structured problem-solving tools is essential to pinpoint root causes accurately. Each tool serves a unique function depending on the complexity of the issue:

5-Why Analysis

This tool involves asking “why” multiple times (typically five) to arrive at the underlying cause of an issue. It is particularly useful for straightforward problems that require a focused investigation.

Fishbone Diagram

The Fishbone diagram, also known as the Ishikawa or cause-and-effect diagram, helps visualize potential causes and categorizations. It is beneficial when analyzing a complex deviation involving multiple factors. This method fosters team collaboration by providing a structured framework for brainstorming.

Fault Tree Analysis

This deductive reasoning tool identifies the pathways that could lead to an undesired outcome. It is particularly effective for complex systems where multiple interactions may contribute to a problem, making it suitable for a comprehensive investigation into viscosity drift.

Selecting the appropriate tool based on the complexity and nature of the issue will enhance the team’s ability to derive informed insights that drive effective CAPA.

Pharma Tip:  Otic Dosage Forms: Safe and Effective Formulations for Ear Drug Delivery

CAPA Strategy

Once the root cause is identified, implementing a robust CAPA strategy is vital for both correction and future prevention:

Correction

This step entails immediately addressing the issue at hand, such as recalibrating equipment, re-evaluating excipient selection, or adjusting batch parameters to align with initial specifications.

Corrective Action

Beyond immediate corrections, effective corrective actions may include design changes in the formulation process, enhanced quality checks, or personnel retraining to prevent recurrence.

Preventive Action

Implement preventive measures that focus on ongoing monitoring and future improvements, such as changes to SOPs or the establishment of a more robust change control process to manage excipient alterations.

Thorough execution of CAPA ensures compliance with GMP expectations and strengthens the overall quality management system.

Related Reads

Control Strategy & Monitoring

Establishing a robust control strategy is essential for fully understanding and managing viscosity fluctuations. Key elements include:

  • Statistical Process Control (SPC): Employ SPC techniques to monitor viscosity data trends in real-time, allowing swift recognition of deviations.
  • Through Sampling: Implement effective sampling methods, including in-process checks for viscosity during critical manufacturing stages.
  • Alarm Systems: Utilize alarm systems for automatic alerts when viscosity exceeds predetermined thresholds, enabling rapid response to issues.
  • Verification Procedures: Schedule regular checks of measuring equipment to ensure accurate data collection and include verification checkpoints in process flows.

Implementing a comprehensive control strategy mitigates the risk of further viscosity drift and enhances product consistency.

Validation / Re-qualification / Change Control Impact

Changes in excipients or process parameters often necessitate validation or re-qualification activities to ensure continued compliance. Key considerations include:

  • Validation: Evaluate any changes made in response to the investigation findings to confirm that they meet specified requirements.
  • Re-qualification: Effectuate re-qualification of equipment and processes that may be impacted by adjustments, ensuring they meet performance criteria.
  • Change Control: Implement or reinforce change control processes to manage any future modifications to excipients or formulations effectively. Proper documentation and validation of each change are mandatory to maintain compliance.

Keeping validation and change control at the forefront ensures ongoing product quality and regulatory adherence.

Inspection Readiness: What Evidence to Show

Demonstrating compliance during regulatory inspections is crucial. Key evidence to prepare includes:

  • Batch Production Records: Maintain thorough documentation of batch production, including monitoring data at each step.
  • Deviation Reports: Document all investigations related to viscosity drift, capturing decision points and actions taken.
  • Standard Operating Procedures (SOPs): Ensure current SOPs are accessible and reflect best practices for process changes and investigations.
  • Training Records: Keep records showing that personnel have received necessary training related to excipient use and viscosity control measures.
Pharma Tip:  Melting Point Failure in suppository manufacturing: CAPA with effectiveness checks for auditors

Having all relevant documentation at the ready fosters confidence during inspections and reflects a commitment to ongoing compliance.

FAQs

What is viscosity drift and why is it a concern?

Viscosity drift refers to unexpected changes in the viscosity of a formulation, which can affect product quality, stability, and compliance with specifications.

How can I identify viscosity drift early during production?

Implementing real-time monitoring of viscosity, alongside regular checks and statistical process control (SPC), helps recognize variations as they occur.

What regulatory guidelines should I follow regarding viscosity specifications?

Follow GMP regulations outlined by FDA, EMA, and MHRA concerning product specifications and process controls.

When should a deviation report be filed?

A deviation report should be filed anytime a specification is not met, promptly documenting the situation, investigation process, and actions taken.

What actions can be taken to prevent recurrence of viscosity drift?

Implementing a robust CAPA plan focused on correcting root causes, enhancing training, and improving process controls are essential preventive measures.

How often should viscosity measurements be conducted?

Conduct viscosity measurements during critical process points and regularly throughout production to ensure consistent results.

What role does change control play in viscosity management?

Change control is crucial for managing alterations to excipients or processes systematically, ensuring all changes are validated and documented.

How do I know which root cause analysis tool to use?

The choice of tool depends on the complexity of the problem: use 5-Why for simple issues and Fishbone or Fault Tree for more complex scenarios.

What documentation is essential during a viscosity drift investigation?

Essential documentation includes batch records, deviation reports, process monitoring data, and SOPs related to the investigation.

What are key metrics to monitor for viscosity control?

Key metrics include viscosity values at various processing stages and the frequency of any deviations from established specifications.

How can I prepare for FDA or EMA inspections regarding viscosity issues?

Ensure documentation is complete, procedures are followed, and all corrective actions are well-documented and supported by data from investigations.

Are there industry standards for viscosity testing?

Yes, industry standards such as those set by USP and ICH provide guidelines for viscosity testing methodologies and specifications.

Also Read